PI Form 4: Diorio Vesting Converts RSUs; Tax Withholding at $184.97
Rhea-AI Filing Summary
Chris Diorio, CEO and director of Impinj Inc. (PI), reported multiple transactions tied to the vesting of restricted stock units (RSUs) on 09/23/2025. Portions of RSU grants vested and were converted into common stock: 2,594; 1,224; and 1,818 shares were recorded as acquired under Rule 16b-3 exemptions, increasing his direct holdings. Concurrently, 2,219 shares were remitted to Impinj to satisfy tax withholding at a price of $184.97 per share. After these transactions, Diorio beneficially owns 356,724 shares directly and 199,362 shares indirectly through DFT L.L.C.
Positive
- Disclosure compliance: Form 4 timely discloses RSU vesting and tax-withholding disposition, meeting Section 16 reporting requirements
- Clear ownership detail: Filing reports both direct (356,724 shares) and indirect (199,362 shares via DFT L.L.C.) beneficial ownership
Negative
- None.
Insights
TL;DR: CEO received vested RSUs and remitted shares for taxes; meaningful insider activity but no open market sales reported.
All reported non-derivative and derivative transactions on 09/23/2025 relate to RSU vesting events. The form shows three RSU vesting tranches converted to common stock (2,594; 1,224; 1,818) and an exempt disposition of 2,219 shares to satisfy withholding at $184.97 per share. The filings confirm both direct and indirect beneficial ownership: 356,724 shares direct and 199,362 indirect via DFT L.L.C. This is routine compensation-related activity, not an open-market sale or acquisition for investment purposes, and contains no new forward-looking corporate actions or material corporate events.
TL;DR: Transactions are standard executive equity vesting and tax withholding; disclosure aligns with Rule 16 reporting.
The Form 4 documents vesting from prior RSU grants dated March 23, 2022/2023/2024, each with one-sixteenth vesting on 09/23/2025. The exempt disposition under Rule 16b-3(e) for tax withholding is explicitly noted. The signature by an attorney-in-fact and the detailed explanatory footnotes meet typical disclosure standards. There are no indications of additional related-party transfers or deviation from customary equity compensation procedures in this filing.